Publication | Closed Access

Interleukin-1α treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2

InflammationAggrecanase-generated G1Gag-substituted Aggrecan ProductsImmunologyMedicineCell BiologyCell SignalingInterleukin-1α Treatment